U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 41 - 43 of 43 results

MELISSA OFFICINALIS WHOLE

MORE DETAILS

YF70189L0N

structurally diverse
Status:
Possibly Marketed Outside US
Source:
NCT02424565: Phase 4 Interventional Completed Pain
(2015)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT02424565
First approved in 1996
Source:
21 CFR 352
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ed39506-3f44-4f5b-ac36-fe1ff264e260
Class:
STRUCTURALLY DIVERSE

ANCHUSA OFFICINALIS WHOLE

MORE DETAILS

T3R944363G

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Canada:ANCHUSA OFFICINALIS
Source URL:
https://tripod.nih.gov/npc/#Download
Class:
STRUCTURALLY DIVERSE

GRATIOLA OFFICINALIS WHOLE

MORE DETAILS

BDD9991A36

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Canada:GRATIOLA OFFICINALIS
Source URL:
https://tripod.nih.gov/npc/#Download
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966